Corcept Therapeutics (CORT)

Corcept Therapeutics (CORT) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• CORT last traded at $80.39, -0.89% on the day.
• Corcept Therapeutics: market cap $8.77B, P/E 156.1, revenue $830.81M over the last four quarters, next earnings 2026-11-03.
• Over the past year CORT returned 11.26%; year to date 131.02%.

Updated 2026-11-02 23:10 UTC